Cellectis S.A. - American Depositary Shares (CLLS) earnings
Quarterly and annual CLLS reports and results, each read against the price at its own news timestamp. Back to the CLLS overview →
5 measured CLLS earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Cellectis Reports Financial Results for the Second Quarter 2026 | Press release | +1.11% | +5.00% | |
| Cellectis Reports Third Quarter 2025 Financial Results and Provides Business Update | Press release | +0.00% | -1.11% | |
| Cellectis to Report Second Quarter 2025 Financial Results on August 4, 2025 | Press release | -4.87% | — | |
| Cellectis to Report Third Quarter 2024 Financial Results on November 4, 2024 | Press release | +3.52% | -1.66% | |
| Cellectis to Report First Quarter 2024 Financial Results on May 28, 2024 | Press release | +0.00% | +2.21% |
Keep exploring
More CLLS: analyst actions → · SEC filings → · CLLS overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Fate Therapeutics, Inc. (FATE) | 287 | -0.76% | 39% |
| RenovaCare, Inc. (RCAR) | 286 | 0.00% | 41% |
| Prestige Consumer Healthcare Inc. (PBH) | 285 | -0.11% | 45% |
| Xencor, Inc. (XNCR) | 285 | +0.09% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.